Literature DB >> 32473106

Genotypic and phenotypic characteristics of acute promyelocytic leukemia translocation variants.

Abdul Mannan1, Ibrahim N Muhsen2, Eva Barragán3, Miguel A Sanz3, Mohamad Mohty4, Shahrukh K Hashmi5, Mahmoud Aljurf6.   

Abstract

Acute promyelocytic leukemia (APL) is a special disease entity of acute myeloid leukemia (AML). The clinical use of all-trans retinoic acid (ATRA) has transformed APL into the most curable form of AML. The majority of APL cases are characterized by the fusion gene PML-RARA. Although the PML-RARA fusion gene can be detected in almost all APL cases, translocation variants of APL have been reported. To date, this is the most comprehensive review of these translocations, discussing 15 different variants. Reviewed genes involved in APL variants include: ZBTB16, NPM, NuMA, STAT5b, PRKAR1A, FIP1L1, BCOR, NABP1, TBLR1, GTF2I, IRF2BP2, FNDC3B, ADAMDTS17, STAT3, and TFG. The genotypic and phenotypic features of APL translocations are summarized. All reported studies were either case reports or case series indicating the rarity of these entities and limiting the ability to drive conclusions regarding their characteristics. However, reported variants have shown variable clinical and morphological features, with diverse responsiveness to ATRA.
Copyright © 2020. Published by Elsevier Ltd.

Entities:  

Keywords:  Acute promyelocytic leukemia; Chimeric proteins; Fusion genes; RARA

Year:  2020        PMID: 32473106     DOI: 10.1016/j.hemonc.2020.05.007

Source DB:  PubMed          Journal:  Hematol Oncol Stem Cell Ther


  6 in total

Review 1.  Cytogenetics analysis as the central point of genetic testing in acute myeloid leukemia (AML): a laboratory perspective for clinical applications.

Authors:  Aliaa Arina Rosli; Adam Azlan; Yaashini Rajasegaran; Yee Yik Mot; Olaf Heidenreich; Narazah Mohd Yusoff; Emmanuel Jairaj Moses
Journal:  Clin Exp Med       Date:  2022-10-13       Impact factor: 5.057

2.  Rare additional chromosomal abnormalities in acute promyelocytic leukaemia resulting in rapidly fatal disease: report of a case.

Authors:  Ahmed Maseh Haidary; Sarah Noor; Sahar Noor; Maryam Ahmad; Ahmad Walid Yousufzai; Ramin Saadaat; Zeeshan Ansar Ahmed; Abdul Jamil Rasooli; Ahmad Shekib Zahier; Haider Ali Malakzai; Abdul Sami Ibrahimkhil; Samuel Sharif; Mohammad Sarwar Anwari; Abdul Hadi Saqib; Tawab Baryali; Najla Nasir
Journal:  EJHaem       Date:  2021-11-30

Review 3.  Mineral medicine: from traditional drugs to multifunctional delivery systems.

Authors:  Xiaoqing Zhong; Zhenning Di; Yuanxin Xu; Qifan Liang; Kuanhan Feng; Yuting Zhang; Liuqing Di; Ruoning Wang
Journal:  Chin Med       Date:  2022-02-10       Impact factor: 5.455

Review 4.  The dual role of autophagy in acute myeloid leukemia.

Authors:  Wonhyoung Seo; Prashanta Silwal; Ik-Chan Song; Eun-Kyeong Jo
Journal:  J Hematol Oncol       Date:  2022-05-07       Impact factor: 23.168

5.  Case Report: Successful therapy with all-trans retinoic acid combined with chemotherapy followed by hematopoietic stem cell transplantation for acute promyelocytic leukemia carrying the BCOR-RARA fusion gene.

Authors:  Li Chen; Hongming Zhu; Yongmei Zhu; Wen Jin; Fangyi Dong; Jianfeng Li; Jiong Hu; Qiusheng Chen; Kankan Wang; Junmin Li
Journal:  Front Oncol       Date:  2022-09-23       Impact factor: 5.738

Review 6.  The Implementation of Mass Spectrometry-Based Proteomics Workflows in Clinical Routines of Acute Myeloid Leukemia: Applicability and Perspectives.

Authors:  Maria Hernandez-Valladares; Øystein Bruserud; Frode Selheim
Journal:  Int J Mol Sci       Date:  2020-09-17       Impact factor: 5.923

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.